Natco Pharma Ltd.

NSE: NATCOPHARM | BSE: 524816 | ISIN: INE987B01026 | Industry: Pharmaceuticals
| Value Stock, Under Radar
795.4000 -25.35 (-3.09%)
NSE Sep 29, 2025 15:31 PM
Volume: 727.8K
 

logo
Natco Pharma Ltd.
21 Nov 2018
795.40
-3.09%
Geojit BNP Paribas
NATCO Pharma (NATCO) is a R&D; focussed, vertically integrated pharmaceutical company with an experienced management team and presence across multiple speciality therapeutic segments. Q2FY19 revenue grew by 35% YoY due to stronger performance from API (up by 30%YoY) and formulation (up by 96%YoY) exports. EBITDA rose by 104% YoY while margin is up by 1520bps primarily driven by revenue from limited competition products in the US. Received court affirmation in favor of prior decisions invalidating...
Natco Pharma Ltd. has lost -43.71% in the last 1 Year
More from Natco Pharma Ltd.
Recommended